Rocket Lab Slides on Iridium Deal Risks

What happened

Rocket Lab's stock is sliding after announcing the $8 billion acquisition of Iridium Communications, with the market reacting to the significant financing and integration risks. The company has grown to over $2 billion in revenue but the deal adds a $3.6 billion bridge loan and potential dilution, as highlighted in the latest DeepValue report. While Rocket Lab's space systems backlog is strong at $2.22 billion and Q1 revenue surged 63.5% YoY, the Iridium acquisition shifts the narrative from a pure-play launch provider to a leveraged space prime. The report notes that the stock already prices in timely Neutron execution and a financeable deal close, leaving limited upside given heavy insider selling and a crowded bullish consensus. Key checkpoints include the filing of the S-4 proxy, Neutron's first flight by Q4 2026, and Iridium financing terms—any slip could push the stock toward the bear case of $48.

Implication

The Iridium deal introduces substantial execution and balance-sheet risk. With the stock at $67.6, the risk/reward is unfavorable until the company demonstrates it can close the acquisition without heavy dilution and deliver Neutron on schedule. A successful Neutron launch and favorable financing terms could validate the bull case of $82, but until then, patience is warranted.

Thesis delta

The market's perception of Rocket Lab has shifted from a high-growth space systems builder to a leveraged acquirer with near-term financing overhang. The Iridium deal, while strategically sound, forces investors to underwrite integration, regulatory, and capital structure risks that were not present in the simpler growth narrative. This change reduces the margin of safety and increases the probability of a downside scenario.